FDA Determines Regulatory Review Period for Light Adjustable Lens Patent Extension

Summary

The US Food and Drug Administration (FDA) has published a notice stating that it has determined the regulatory review period for the patent extension of Light Adjustable Lens, following submissions to the US Patent and Trademark Office (USPTO) for patent extension.